Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
About this item
Full title
Author / Creator
Su, Hai-xia , Yao, Sheng , Zhao, Wen-feng , Li, Min-jun , Liu, Jia , Shang, Wei-juan , Xie, Hang , Ke, Chang-qiang , Hu, Hang-chen , Gao, Mei-na , Yu, Kun-qian , Liu, Hong , Shen, Jing-shan , Tang, Wei , Zhang, Lei-ke , Xiao, Geng-fu , Ni, Li , Wang, Dao-wen , Zuo, Jian-ping , Jiang, Hua-liang , Bai, Fang , Wu, Yan , Ye, Yang and Xu, Ye-chun
Publisher
Singapore: Springer Singapore
Journal title
Language
English
Formats
Publication information
Publisher
Singapore: Springer Singapore
Subjects
More information
Scope and Contents
Contents
Human infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19) and there is no cure currently. The 3CL protease (3CLpro) is a highly conserved protease which is indispensable for CoVs replication, and is a promising target for development of broad-spectrum antiviral drugs. In this study...
Alternative Titles
Full title
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7393338
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7393338
Other Identifiers
ISSN
1671-4083
E-ISSN
1745-7254
DOI
10.1038/s41401-020-0483-6
